Blazing a trail for iPSC-derived cell therapy in the hair loss space

Cell & Gene Therapy Insights 2024; 10(1), 91–97

DOI: 10.18609/cgti.2024.016

Published: 15 February
Kevin D’Amour

In the less than two decades since their discovery, induced pluripotent stem cells have proven transformational for the cell therapy field. In this interview David McCall, Senior Editor, Cell & Gene Therapy Insights, and Kevin D’Amour, Chief Scientific Officer, Stemson Therapeutics, explore the inexorable rise of induced pluripotent stem cells, their current applications in hair loss, and the future evolution of the space.